1,550
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis

, , , , &
Pages 1466-1477 | Received 29 Mar 2021, Accepted 20 Apr 2021, Published online: 14 Jul 2021

References

  • Abdelzaher WY, Ahmed SM, Welson NN, et al. (2021). Vinpocetine ameliorates L-arginine induced acute pancreatitis via Sirt1/Nrf2/TNF pathway and inhibition of oxidative stress, inflammation, and apoptosis. Biomed. Pharmacother 133:110976.
  • Brambila CJ, Lux J, Mattrey RF, et al. (2020). Bubble inflation using phase-change perfluorocarbon nanodroplets as a strategy for enhanced ultrasound imaging and therapy. Langmuir 36:2954–65.
  • Chen J, Ratnayaka S, Alford A, et al. (2017). Theranostic multilayer capsules for ultrasound Imaging and guided drug delivery. ACS Nano 11:3135–46.
  • Chen J, Wang X, Chen J, et al. (2021). New equation to decipher the relationship between carbon isotopic composition of methane and maturity of gas source rocks. Sci China Earth Sci 64:470–93.
  • Chen S, Xu XL, Zhou B, et al. (2019a). Acidic pH-activated gas-generating nanoparticles with pPullulan decorating for hepatoma-targeted ultrasound imaging. ACS Appl Mater Interfaces 11:22194–205.
  • Chen Z, Chattaraj R, Pulsipher KW, et al. (2019b). Photoacoustic and Ultrasound Dual-Mode Imaging via Functionalization of Recombinant Protein-Stabilized Microbubbles with Methylene Blue. ACS Appl Bio Mater 2:4020–6.
  • Chen Y, Sun M. (2021). Two-dimensional WS2/MoS2 heterostructures: properties and applications. Nanoscale 13:5594–619.
  • Chertok B, Langer R, Anderson DG. (2016). Spatial control of gene expression by nanocarriers using heparin masking and ultrasound-targeted microbubble destruction. ACS Nano 10:7267–78.
  • Chung CYS, Fung SK, Tong KC, et al. (2017). A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-delivery. Chem. Sci 8:1942–53.
  • Delplace V, Couvreur P, Nicolas J. (2014). Recent trends in the design of anticancer polymer prodrug nanocarriers. Polym. Chem 5:1529–44.
  • Deng B, Ma P, Xie Y. (2015). Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review. Nanoscale 7:12773–95.
  • Dilnawaz F, Singh A, Mohanty C, Sahoo SK. (2010). Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31:3694–706.
  • Ding J, Chen J, Gao L, et al. (2019). Engineered nanomedicines with enhanced tumor penetration. Nano Today 29:100800.
  • Escudero-Duch C, Martin-Saavedra F, Prieto M, et al. (2019). Gold nanoparticles for the in situ polymerization of near-infrared responsive hydrogels based on fibrin. Acta Biomater 100:306–15.
  • Feng X, Xu W, Liu J, et al. (2021). Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy. Sci. Bull 66:362–73.
  • Guo S, Zhang Y, Wu Z, et al. (2019). Synergistic combination therapy of lung cancer: cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-demethylnobiletin. Biomed. Pharmacother 118:109225.
  • Guo Y, Wang XY, Chen YL, et al. (2018). A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Acta Biomater 80:308–26.
  • Heo J, Lim CK, Min HS, et al. (2019). Rational design of inflammation-responsive inflatable nanogels for ultrasound molecular imaging. Chem Mater 31:2905–12.
  • Hu JJ, Liu MD, Chen Y, et al. (2019). Immobilized liquid metal nanoparticles with improved stability and photothermal performance for combinational therapy of tumor. Biomaterials 207:76–88.
  • Huang Y, Xie D, Gou S, et al. (2021a). Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer. Nanoscale 13:5765–79.
  • Huang Z, Sun M, Li Y, et al. (2021b). Reduced graphene oxide-coated electrospun fibre: effect of orientation, coverage and electrical stimulation on Schwann cells behavior. J Mater Chem B 9:2656–65.
  • Kang C, Sun Y, Zhu J, et al. (2016). Delivery of nanoparticles for treatment of brain tumor. Curr Drug Metab 17:745–54.
  • Kheirolomoom A, Mahakian LM, Lai CY, et al. (2010). Copper − doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. MolPharm 7:1948–58.
  • Kim J, Pramanick S, Lee D, et al. (2015). Polymeric biomaterials for the delivery of platinum-based anticancer drugs. Biomater Sci 3:1002–17.
  • Lainović T, Margueritat J, Martinet Q, et al. (2020). Micromechanical imaging of dentin with Brillouin microscopy. Acta Biomater 105:214–22.
  • Li D, Su T, Ma L, et al. (2020). Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy. Eur J Med Chem 199:112367.
  • Li X, Gao Y. (2020). Synergistically fabricated polymeric nanoparticles featuring dual drug delivery system to enhance the nursing care of cervical cancer. Process Biochem 98:254–61.
  • Li Y, Chen Y, Du M, Chen ZY. (2018). Ultrasound technology for molecular imaging: from contrast agents to multimodal imaging. ACS Biomater Sci Eng 4:2716–28.
  • Liu D, Chen L, Chen W, et al. (2021). Enhanced visible-light photocatalytic activity of perylene diimide (PDI) supramolecular nanorods with Pt QDs deposited in situ. Dalt Trans 50:4008–16.
  • Liu D, Liu Z, Wang L, et al. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces 85:262–9.
  • Liu TY, Huang TC. (2011). A novel drug vehicle capable of ultrasound-triggered release with MRI functions. Acta Biomater 7:3927–34.
  • Liu Y, Xu H, Li T, Wang W. (2021). Microtechnology-enabled filtration-based liquid biopsy: challenges and practical considerations. Lab Chip 21:994–1015.
  • Lux J, Vezeridis AM, Hoyt K, et al. (2017). Thrombin-activatable microbubbles as potential ultrasound contrast agents for the detection of acute thrombosis. ACS Appl Mater Interfaces 9:37587–96.
  • Ma W, Chen Q, Xu W, et al. (2021). Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer. Nano Res 14:846–57.
  • Mohamed Subarkhan MK, Ramesh R, Liu Y. (2016). Synthesis and molecular structure of arene ruthenium(ii) benzhydrazone complexes: impact of substitution at the chelating ligand and arene moiety on antiproliferative activity. New J Chem 40:9813–23.
  • Mohamed Subarkhan MK, Ren L, Xie B, et al. (2019). Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Eur J Med Chem 179: 246–56.
  • Mohan N, Mohamed Subarkhan MK, Ramesh R. (2018). Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands. J Organomet Chem 859:124–31.
  • Mohamed Kasim MS, Sundar S, Rengan, R. (2018). Synthesis and structure of new binuclear ruthenium(ii) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 5:585–96.
  • Oliveira EP, Malysz-Cymborska I, Golubczyk D, et al. (2019). Advances in bioinks and in vivo imaging of biomaterials for CNS applications. Acta Biomater 95:60–72.
  • Padmanabhan P, Kumar A, Kumar S, et al. (2016). Nanoparticles in practice for molecular-imaging applications: an overview. Acta Biomater 41:1–16.
  • Paris JL, de la Torre P, Cabañas MV, et al. (2019). Suicide-gene transfection of tumor-tropic placental stem cells employing ultrasound-responsive nanoparticles. Acta Biomater 83:372–8.
  • Parker JP, Ude Z, Marmion CJ. (2016). Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. Metallomics 8:43–60.
  • Picheth G, Houvenagel S, Dejean C, et al. (2017). Echogenicity enhancement by end-fluorinated polylactide perfluorohexane nanocapsules: towards ultrasound-activable nanosystems. Acta Biomater 64:313–22.
  • Raudenska M, Balvan J, Fojtu M, et al. (2019). Unexpected therapeutic effects of cisplatin. Metallomics 11:1182–99.
  • Sanna V, Pintus G, Bandiera P, et al. (2011). Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents. Mol Pharm 8:748–57.
  • Santha Moorthy M, Subramanian B, Panchanathan M, et al. (2017). Fucoidan-coated core-shell magnetic mesoporous silica nanoparticles for chemotherapy and magnetic hyperthermia-based thermal therapy applications. New J Chem 41:15334–46.
  • Sathiya Kamatchi T, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Dalton Trans 49:11385–95.
  • Shi B, Zhang B, Zhang Y, et al. (2020). Multifunctional gap-enhanced Raman tags for preoperative and intraoperative cancer imaging. Acta Biomater 104:210–20.
  • Singh RK, Patel KD, Mahapatra C, et al. (2019). Combinatory cancer therapeutics with nanoceria-capped mesoporous silica nanocarriers through pH-triggered drug release and redox activity. ACS Appl Mater Interfaces 11:288–99.
  • Sokolova V, Nzou G, van der Meer SB, et al. (2020). Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model. Acta Biomater 111:349–62.
  • Song S, Guo H, Jiang Z, et al. (2015). Self-assembled microbubbles as contrast agents for ultrasound/magnetic resonance dual-modality imaging. Acta Biomater 24:266–78.
  • Subarkhan MKM, Ramesh R. (2016). Ruthenium(ii) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity. Inorg Chem Front 3:1245–55.
  • Szablowski JO, Bar-Zion A, Shapiro MG. (2019). Achieving spatial and molecular specificity with ultrasound-targeted biomolecular nanotherapeutics. Acc Chem Res 52:2427–34.
  • Tang H, Guo Y, Peng L, et al. (2018). In Vivo targeted, responsive, and synergistic cancer nanotheranostics by magnetic resonance imaging-guided synergistic high-intensity focused ultrasound ablation and chemotherapy. ACS Appl Mater Interfaces 10:15428–41.
  • Toumia Y, Cerroni B, Domenici F, et al. (2019). Phase change ultrasound contrast agents with a photopolymerized diacetylene shell. Langmuir 35:10116–27.
  • Wang J, Qin B, Chen X, et al. (2017). Ultrasound molecular imaging of angiogenesis using vascular endothelial growth factor-conjugated microbubbles. Mol Pharm 14:781–90.
  • Wang J, Xu W, Zhang N, et al. (2021). X-ray-responsive polypeptide nanogel for concurrent chemoradiotherapy. J Control Release 332:1–9.
  • Wang L, Lu H, Gao Q, et al. (2019). A multifunctional theranostic contrast agent for ultrasound/near infrared fluorescence imaging-based tumor diagnosis and ultrasound-triggered combined photothermal and gene therapy. Acta Biomater 99:373–86.
  • Wu M, Xiong H, Zou H, et al. (2018). A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells. Acta Biomater 70:211–26.
  • Xiao S, Tang Y, Lin Y, et al. (2020). Tracking osteoarthritis progress through cationic nanoprobe-enhanced photoacoustic imaging of cartilage. Acta Biomater 109:153–62.
  • Zhang W, Jin X, Li H, et al. (2018). Injectable and body temperature sensitive hydrogels based on chitosan and hyaluronic acid for pH sensitive drug release. Carbohydr Polym 186:82–90.
  • Zhang W, Zhang C, Wang XY, et al. (2020). Light-responsive core–shell nanoplatform for bimodal imaging-guided photothermal therapy-primed cancer immunotherapy. ACS Appl Mater Interfaces 12:48420–31.
  • Zheng J, Peng X, Wang Z. (2021). Plasma-assisted defect engineering of N-doped NiCo2O4 for efficient oxygen reduction. Phys Chem Chem Phys 23:6591–9.
  • Zheng P, Liu Y, Chen J, et al. (2020). Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery. Chinese Chem Lett 31:1178–82.
  • Zhu X, Han W, Liu Y, et al. (2021). Rational design of a prodrug to inhibit self-inflammation for cancer treatment. Nanoscale 13:5817–25.